- Title:
Schedule One - Optima Health Group PLC - Time:
08:00:00 - Date:
8 Sept 2021 - Category:
Capital structure - ID:
0246L
|
ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES") |
||||||||||||
|
|
||||||||||||
|
COMPANY NAME: |
||||||||||||
|
Optima Health Group plc ("Optima Health" or the "Group")
|
||||||||||||
|
COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) : |
||||||||||||
|
Registered address:
Meadow Court 2 Hayland Street Sheffield United Kingdom S9 1BY United Kingdom
Trading address:
Grosvenor House, Prospect Hill Redditch Worcestershire B97 4DL United Kingdom
|
||||||||||||
|
COUNTRY OF INCORPORATION: |
||||||||||||
|
United Kingdom
|
||||||||||||
|
COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26: |
||||||||||||
|
Company website address containing all information required by AIM Rule 26 from admission: TBC
|
||||||||||||
|
COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED: |
||||||||||||
|
Optima Health is the UK's leading provider by size of technology enabled corporate health and wellbeing solutions. The Group aims to empower organisations to bring out the best in their people, and themselves, by actively managing their health and wellbeing, and supports workplace wellbeing with digitally connected health solutions. Underpinned by a robust clinical governance framework, the Group leverages its proprietary technology and flexible delivery model to foster healthy high performance.
The Group's main country of operation is the UK.
|
||||||||||||
|
DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares): |
||||||||||||
|
Number of ordinary shares of 0.25 pence each ("Ordinary Shares") for which Admission will be sought: TBC
Issue price per Ordinary Share: TBC
No restrictions exist on the transferability of Ordinary Shares.
No Ordinary Shares will be held in treasury on Admission to AIM.
|
||||||||||||
|
CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION: |
||||||||||||
|
Capital to be raised on Admission: TBC
Anticipated market capitalisation on Admission: TBC
|
||||||||||||
|
PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION: |
||||||||||||
|
TBC
|
||||||||||||
|
DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED: |
||||||||||||
|
There are no other exchanges or trading platforms to which the Group has applied or agreed to have the Ordinary Shares admitted or traded.
|
||||||||||||
|
FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known): |
||||||||||||
|
Steven Jonathan Owen, Non-executive Chairman
Simon Ashley Arnold, Chief Executive Officer
Jonathan (Jonny) David Thomas, Chief Financial Officer
Anand Jagdishchandra Jain, Non-executive Director
John Robert Stier, Independent Non-executive Director
Joanne (Jo) Mary Easton, Independent Non-executive Director
Andrew (Andy) David Williams, Independent Non-executive Director
|
||||||||||||
|
FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known): |
||||||||||||
|
|
||||||||||||
|
NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES: |
||||||||||||
|
None
|
||||||||||||
|
(i) ANTICIPATED ACCOUNTING REFERENCE DATE (ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information) (iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19: |
||||||||||||
|
(i) 31 December (ii) 30 June 2021 (audited interim results) (iii) 30 June 2022 (annual accounts for the year ending 31 December 2021) 30 September 2022 (interim results for the six months ending 30 June 2022) 30 June 2023 (annual accounts for the year ending 31 December 2022)
|
||||||||||||
|
EXPECTED ADMISSION DATE: |
||||||||||||
|
Late September 2021
|
||||||||||||
|
NAME AND ADDRESS OF NOMINATED ADVISER: |
||||||||||||
|
Numis Securities Limited 45 Gresham Street EC2V 7BF London
|
||||||||||||
|
NAME AND ADDRESS OF BROKER: |
||||||||||||
|
Numis Securities Limited 45 Gresham Street EC2V 7BF London
|
||||||||||||
|
OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES: |
||||||||||||
|
Copies of the admission document will be available free of charge during normal business hours on any day (except Saturdays, Sundays and public holidays) at the registered offices of the Group. The admission document will also be available on the Company's website.
The admission document will contain full details about the applicant and the admission of its securities.
|
||||||||||||
|
THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY |
||||||||||||
|
The Quoted Companies Alliance Corporate Governance Code
|
||||||||||||
|
DATE OF NOTIFICATION: |
||||||||||||
|
8 September 2021
|
||||||||||||
|
NEW/ UPDATE: |
||||||||||||
|
NEW
|
Schedule One - Optima Health Group PLC08:00:008 Sept 2021Capital structure0246L